Sun Pharmaceutical Industries Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- A-7 & A-8, MIDC Industrial Area, Ahilyanagar, Maharashtra 414111, India (IND)
- Operations here
- analysisapi manufacturemanufacture
- FDA identifiers
- FEI 3003227153 · DUNS 862278942
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2020-01-24
- VAIDrug Quality Assurance2018-04-20
- VAIDrug Quality Assurance2015-06-19
- VAIDrug Quality Assurance2012-09-30
- NAIDrug Quality Assurance2009-02-12
Drugs this plant is listed as making
2 distinct drugs across 9 products name this site in their FDA label.
- MesalamineSun Pharmaceutical Industries, Inc.
- Metoprolol SuccinateSun Pharmaceutical Industries Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.